Vasovagal syncope

Česká verzia

Authors: M. Křivánková ¹; V. Doupal ²; P. Heinc ²; J. Zapletalová ³
Authors place of work: ¨1Urgentní příjem FN Olomouc Primář: MUDr. Petr Hubáček ; I. interní klinika FN Olomouc Přednosta: doc. MUDr. Miloš Táborský, CSc., FESC, MBA ²; Ústav lékařské biofyziky LF UP Olomouc Přednostka: doc. RNDr. Hana Kolářová, CSc. ³
Published in the journal: Prakt. Lék. 2011; 91(6): 350-354
Category: Of different specialties

Summary

This study analysed patients admitted to the 1st Internal Clinic of Olomouc University Hospital diagnosed with vasovagal syncope, focusing on their diagnosis and a comparison of patients suffering from vasovagal syncope treated by beta-blockers and patients without treatment. The results were compared with the general consensus.

The study lasted for 2 years, during which a total of 7.507 patients were admitted to the aforementioned clinic. Vasovagal syncope was confirmed in 48 cases. There was no significant difference in age or sex in the evaluated group of patients, nor was there a difference in relapses between patients treated and those not treated with beta-blockers.

Key words:
syncope vasovagal, diagnostic, possible treatment, comparison of possible treatments.

Zdroje

1. Kautzner, J. Synkopa: Diagnostika a léčba, doporučené postupy pro kardiologii. Cor Vasa 2007, 49(2), K43–K53.

2. Kautzner, J., Doupal, V. Synkopa: Diagnostika a léčba. Doporučené postupy v kardiologii, část II, 2000, s. 47-55.

3. Lukl, J. Srdeční arytmie, aktuální problémy. Praha: Grada Publishing, 1998, s. 17-55.

4. Kenny, R.A., Ingram, A., Baylis, J., Sutton R. Head-up tilt test: A useful test for investigating unexplained syncope. Lancet 1986, 327, p. 1352-1354.

5. Grubb, B.P., Karas, B. Diagnosis and management of neurocardiogenic syncope. Curr. Opin. Cardiol. 1998, 13, p. 29-35.

6. Kaufmann, H. Neurally mediated syncope: Pathogenesis, diagnosis, and treatment. Neurology 1995, 45 (Suppl 5), p. 12-18.

7. Robotis, D.A., Huang, D.T., Daubert, J. Head-up tilt-table testing: An overview. Ann. Non Inv. Electrocardiol. 1999, 4, p. 212-218.

8. Sneddon, J.F., Bashir, Y., Murgatroyd F.D. et al. Do patiens with neurally mediated syncope have augmented vagal tone? Amer. J. Cardiol. 1993, 72, p. 1314-1315.

9. Sheldon, R.S., Wilson, W. Heart rate variability analysis of autonomic tone in patiens with neurocardiogenic syncope (abstr). Circulation 1991, 84 (supl. II), p. 233.

10. Simone, F., Buonomo, C., Nozzoli, C. et al. Vasovagal reactions induced by head-up tilt and tests of vagal cardiac function. J. Auton. Nerv. Syst. 1990, 30, p. 145-148.

11. Theodorakis, G.N., Kremastinos, D.T., Stefanakis, GS., et al. The effectivenes of blockade and its influence on heart rate variability in vasovagal patiens. Eur. Heart. J. 1993, 14, p. 1499-1507.

12. Sra, J., Murthy, V.S., Jazayeri, M.R. et al. Use intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patiens with neurocardiogenic syncope. J. Amer. Coll. Cardiol. 1992, 19, p. 592.

13. Brignole, M., Alboni, P., Beneditt, D.G. et al. The task force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope - Update 2004. Eur. Heart. J. 2004, 25(22), p. 2054-2072.

14. Wang, C.C., Yeh, S.J., Wen MS. Worsening of vasovagal syncope after B-blocker therapy. Chest. 1994, 106, p. 963-965.

15. Sheldon, R.S., Connolly, S., Rose, S. et al. Prevention of Syncope Trial (POST) -

a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006, 113, p. 1164-1170.

16. Mahanonda, N., Bhuripanya, K., Kangkagate, C. et al. Randomized placebo controlled trial of oral atenolol in patiens with unexplained syncope and positive upright tilt-table test results. Am. Heart. J. 1995, 130, p. 1250-1253.

17. Jhamb, D.K., Singh, B., Sharda, B. et al. Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response. Am. Heart. J. 1996, 132, p. 608-611.

18. Biffi, M., Boriani, G., Sabatani, P. et al. Malignant vasovagal syncope: A randomized trial of metoprolol and clonidine. Heart 1997, 77, p. 268-272.

19. Madrid, A., Ortega, I., Rebollo, G.J. et al. Lack of efficacy of atenolol for the prevention of neurally-mediated syncope in highly symptomatic population: A prospective double-blind randomized and placebo-controlled study. J. Am. Coll. Cardiol. 2001, 37, p. 554-557.

20. Flevari, P., Livanis, E., Theodorakis, G. et al. Vasovagal syncope: A prospective randomized, cross-over evaluation of the effects of propranolol, nadolol and placebo on syncope recurrence and patiens well-being. J. Am. Coll. Cardiol. 2002, 40, p. 499-504.

21. Killam, S., Sheldon, R. Are beta blockers prosyncopal medications? J. Am. Coll. Cardiol. 1993, 21, p. 111.

22. Curwin, J.H., McGovern, B.A., Garah, H. et al. The role of medical therapy is uncertain in patiens with recurrent syncope and positive tilt table test. J. Am. Coll. Cardiol. 1994, p. 330.